Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
US Heart and Vascular provides non-clinical support services to independent cardiovascular physician practices across the United States. The company partners with leading cardiology groups to enable high-quality patient care through business management, access to growth capital, operational best practices, and value-based care infrastructure. It does not develop drugs or devices but focuses on empowering cardiologists to thrive in an evolving healthcare landscape by improving outcomes and reducing costs.
The company has rapidly expanded its network since its founding in 2021 through partnerships with major cardiovascular practices in Texas (including the large group "HeartPlace"), Arizona, Kansas, Alabama ("Birmingham Heart Clinic"), among others. Backed by private equity firms Rubicon Founders and Ares Management Corporation, it aims to build the premier national value-based cardiovascular care model.
No clinical trial results or drug pipeline exist as it does not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on US Heart and Vascular.